Y RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Self-confidence limitb four.955 ?0.021 10.02 ?0.078 14.91 ?0.173 four.965 ?0.026 9.95 ?0.09 20.10 ?0.231 Recovery 99.60 99.80 99.20 one N-type calcium channel Antagonist manufacturer hundred.60 99.40 99.Precision RSD a 0.51 0.75 1.02 0.40 0.68 0.Interday Accuracy RE -0.40 0.20 -0.80 0.60 -0.60 -0.Self-assurance limitb four.98 ?0.025 9.98 ?0.075 14.88 ?0.152 five.03 ?0.020 9.94 ?0.068 19.92 ?0.abMean of six determinations; RSD : percentage relative standard deviation; RE : percentage relative error. Self-assurance limit at 95 self-confidence level and five degrees of freedom ( = two.571).Journal of Analytical Procedures in ChemistryJournal of Analytical Methods in ChemistryTable five: Determination of GMF in its pharmaceutical dosage types applying the standard addition technique.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )two.BCG2.BCP2.BPB2.BTB5.MO4.0 eight.0 12 two.0 6.0 ten 4.0 eight.0 12 four.0 8.0 12 five.0 10Factive tablets Flobiotic tablet GemiQue tablets Total identified (g mL-1 ) Recovery a ?SD Total identified (g mL-1 ) Recovery ?SD Total found (g mL-1 ) Recovery ?SD five.96 99.30 ?0.78 five.98 99.60 ?0.67 six.02 100.30 ?0.51 9.91 99.10 ?1.02 10.02 one hundred.20 ?0.82 9.92 99.20 ?0.70 13.97 99.80 ?1.24 13.96 99.70 ?1.09 13.99 99.90 ?0.94 3.996 99.90 ?0.66 3.96 99.10 ?0.42 three.97 99.30 ?0.38 eight.02 one hundred.20 ?0.90 7.98 99.80 ?0.69 7.99 99.90 ?0.84 11.92 99.30 ?0.95 12.05 100.40 ?1.03 11.95 99.60 ?1.17 5.97 99.50 ?0.57 five.99 99.80 ?0.36 six.01 one hundred.15 ?0.76 9.97 99.70 ?0.76 9.96 99.60 ?0.49 9.97 99.70 ?0.96 13.87 99.10 ?1.14 13.97 99.90 ?0.78 13.89 99.20 ?1.21 six.03 one hundred.50 ?0.48 6.01 one hundred.ten ?0.53 6.01 one hundred.10 ?0.54 9.90 99.00 ?0.72 9.96 99.60 ?0.85 9.96 99.60 ?1.03 13.93 99.50 ?0.97 13.96 99.70 ?1.31 14.04 100.30 ?1.15 9.97 99.70 ?0.32 9.91 99.10 ?0.70 9.99 99.90 ?0.65 14.94 99.60 ?0.56 15.06 100.40 ?1.05 14.97 99.80 ?0.85 24.95 99.80 ?0.90 24.88 99.50 ?1.25 24.90 99.60 ?1.aAverage of six determinations.Table six: Determination of MXF in its pharmaceutical dosage types applying the typical addition approach.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )two.BCP2.BPB2.BTB5.MO2.0 six.0 10 4.0 8.0 12 2.0 four.0 eight.0 five.0 10Avelox tablets Moxiflox tablets Moxifloxacin tablets Total discovered (g mL-1 ) Recovery a ?SD Total located (g mL-1 ) Recovery ?SD Total found (g mL-1 ) Recovery ?SD 3.98 99.40 ?0.56 three.96 99.10 ?0.62 3.98 99.60 ?0.48 7.98 99.70 ?0.83 eight.06 one hundred.70 ?0.89 7.98 99.80 ?1.10 11.89 99.ten ?1.20 12.02 one hundred.20 ?1.26 11.92 99.30 ?1.17 5.98 99.60 ?0.61 five.97 99.50 ?0.35 five.96 99.30 ?0.36 9.99 99.90 ?0.84 9.96 99.60 ?0.60 9.99 99.90 ?0.63 14.07 100.50 ?1.14 13.99 99.90 ?0.85 14.08 one hundred.60 ?1.36 3.98 99.50 ?0.48 three.97 99.20 ?0.33 four.01 100.20 ?0.61 five.95 99.20 ?0.92 5.99 99.80 ?0.65 5.96 99.30 ?0.84 10.04 100.40 ?1.17 ten.01 100.ten ?0.93 9.95 99.50 ?1.07 9.91 99.ten ?0.42 9.94 99.40 ?0.37 9.95 99.50 ?0.45 15.08 100.50 ?0.76 15.03 one hundred.20 ?0.75 14.97 99.80 ?0.85 19.90 99.50 ?1.16 19.92 99.60 ?1.28 19.83 99.15 ?0.Journal of Analytical Methods in ChemistryaAverage of six determinations.Journal of Analytical Techniques in ChemistryTable 7: Determination of ENF in its pharmaceutical dosage types applying the normal addition approach. ReagentTaken (g mL-1 ) Pure drug added (g mL-1 ) 5.0 BCG 5.0 BBTBa5.0 ten 15 five.0 10Enrocin 10 S1PR1 Modulator review injectable Avitryl 20 injectable Total identified (g mL-1 ) Recovery a ?SD Total identified (g mL-1 ) Recovery ?SD 9.92 99.20 ?0.48 9.94 99.40 ?0.46 14.94 99.60 ?0.66 15.20 one hundred.ten ?0.72 19.98 10.05 14.91 19.84 99.90 ?0.82 100.50 ?0.56 99.40 ?0.83 99.20 ?1.20 19.90 9.97 15.05 19.82 99.50 ?1.05 99.70 ?0.52 100.30 ?0.69 99.10 ?0.
